Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging
Journal of Magnetic Resonance Imaging · 2023
DOI: 10.1002/jmri.28606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2023. Verfasst von Junjie Li und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Brain Neoplasms, Deep Learning, Glioma, Spinal Cord Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Department of Health, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Determination of H3 K27M mutation in diffuse midline glioma (DMG) is key for prognostic assessment and stratifying patient subgroups for clinical trials. MRI can noninvasively depict morphological and metabolic characteristics of H3 K27M mutant DMG.
Purpose
This study aimed to develop a deep learning (DL) approach to noninvasively predict H3 K27M mutation in DMG using T2‐weighted images. Study Type Retrospective and prospective. Population For diffuse midline brain gliomas, 341 patients from Center‐1 (27 ± 19 years, 184 males), 42 patients from Center‐2 (33 ± 19 years, 27 males) and 35 patients (37 ± 18 years, 24 males). For diffuse spinal cord gliomas, 133 patients from Center‐1 (30 ± 15 years, 80 males). Field Strength/Sequence 5T and 3T, T2‐weighted turbo spin echo imaging. Assessment Conventional radiological features were independently reviewed by two neuroradiologists. H3 K27M status was determined by histopathological examination. The Dice coefficient was used to evaluate segmentation performance. Classification performance was evaluated using accuracy, sensitivity, specificity, and area under the curve. Statistical Tests Pearson's Chi‐squared test, Fisher's exact test, two‐sample Student's t ‐test and Mann–Whitney U test. A two‐sided P value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Medical Imaging Product, Neusoft, Group Ltd., Shenyang, People's Republic of China.
- BioMind Inc., Beijing, People's Republic of China.
- Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Radiology, West China Hospital of Sichuan University, Chengdu, People's Republic of China.
Förderung
- Department of Health
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Zhang, P., Qu, L., Sun, T., Duan, Y., Wu, M., Weng, J., Li, Z., Gong, X., Liu, X., Wang, Y., Jia, W., Su, X., Yue, Q., Li, J., Zhang, Z., Barkhof, F., Huang, R. Y., Chang, K., …, & Liu, Y. (2023). Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.28606
Vancouver
Li J, Zhang P, Qu L, Sun T, Duan Y, Wu M, et al. Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging. Journal of Magnetic Resonance Imaging. 2023. doi:10.1002/jmri.28606
BibTeX
@article{Li2023,
author = {Li, Junjie and Zhang, Peng and Qu, Liying and Sun, Ting and Duan, Yunyun and Wu, Minghao and Weng, Jinyuan and Li, Zhaohui and Gong, Xiaodong and Liu, Xing and Wang, Yongzhi and Jia, Wenqing and Su, Xiaorui and Yue, Qiang and Li, Jianrui and Zhang, Zhiqiang and Barkhof, Frederik and Huang, Raymond Y and Chang, Ken and Sair, Haris and Ye, Chuyang and Zhang, Liwei and Zhuo, Zhizheng and Liu, Yaou},
title = {Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging},
journal = {Journal of Magnetic Resonance Imaging},
year = {2023},
doi = {10.1002/jmri.28606}
}
EUVIMED